Integrase inhibitors in late pregnancy and rapid HIV viral load reduction
- 1 March 2016
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 214 (3) , 385.e1-385.e7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Time to viral load suppression in antiretroviral‐naive and ‐experienced HIV‐infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestationBJOG: An International Journal of Obstetrics & Gynaecology, 2013
- Rapid Decline in HIV Viral Load When Introducing Raltegravir-Containing Antiretroviral Treatment Late in PregnancyAIDS Patient Care and STDs, 2012
- A Framework for Elimination of Perinatal Transmission of HIV in the United StatesPediatrics, 2012
- When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?AIDS, 2012
- Raltegravir once daily or twice daily in previously untreated patients with HIV-1: a randomised, active-controlled, phase 3 non-inferiority trialThe Lancet Infectious Diseases, 2011
- High neonatal concentrations of raltegravir following transplacental transfer in HIV-1 positive pregnant womenAIDS, 2010
- Rapid HIV-RNA decline following addition of raltegravir and tenofovir to ongoing highly active antiretroviral therapy in a woman presenting with high-level HIV viraemia at week 38 of pregnancyJournal of Antimicrobial Chemotherapy, 2010
- Use of Newer Antiretroviral Agents, Darunavir and Etravirine with or without Raltegravir, in Pregnancy: A Report of two CasesAntiviral Therapy, 2009
- Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006AIDS, 2008
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994